Invitae deploys Apple Watch for cardiovascular genetics study
November 15, 2019 -- Invitae has developed a research platform that links test results for genetic conditions with biometric data amassed on the Apple Watch.
Quest reports supportive data for new HDL cholesterol function test
November 15, 2019 -- Quest Diagnostics reported data supporting its new test for high-density lipoprotein (HDL) cholesterol function at the American Heart Association annual meeting, ahead of the product's U.S. rollout sometime in 2020.
Blood test for predicting sepsis death in kids steps closer to reality
November 14, 2019 -- Rapid blood test results for five biomarkers correlated with sepsis outcomes in a study of children treated in intensive care units, which suggests potential for use as a predictive test for risk of death. The findings were published online November 13 in Science Translational Medicine.  Discuss
Becton Dickinson files for Onclarity FDA approval in 11 more HPV types
November 14, 2019 -- Becton Dickinson has submitted a premarket approval filing with the U.S. Food and Drug Administration (FDA) for its Onclarity test for an expanded number of HPV genotypes.
Momentum builds for tests that predict kidney damage
November 13, 2019 -- New studies show the potential for lab tests to help predict damage to kidneys in different settings -- one in kids in intensive care units and the other in diverse, multinational populations of adults. The two studies, both of which were reported separately in November, build hopes for prevention in the future.  Discuss
Paige pathology AI products cleared for Europe
November 13, 2019 -- Paige's Paige Insight artificial intelligence (AI)-native digital pathology slide viewer and Paige Prostate module for prostate cancer detection have both received the CE Mark for primary diagnosis, paving the way for use in Europe.
NantHealth's tumor mutation test cleared for U.S.
November 13, 2019 -- NantHealth's Omics Core whole exome sequencing IVD test for tumor mutational burden profiling in solid tumors has received 510(k) clearance from the U.S. Food and Drug Administration.
AMP highlights: Products aim to beat the clock in cancer detection
November 11, 2019 -- Cancer was a key focus at the recent Association for Molecular Pathology (AMP) annual meeting in Baltimore -- particularly faster detection and treatment selection, according to Bruce Carlson, publisher of Kalorama Information.  Discuss
Older women miss out on cervical cancer screening
November 11, 2019 -- U.S. surveys of women ages 45 to 65 show that cervical cancer screening rates are subpar, even though this type of cancer often occurs later in life, researchers reported in the journal Preventive Medicine.
CDC finds vitamin E acetate in 100% of vaping cases
November 8, 2019 -- In news that sheds light on the recent outbreak of vaping-related lung disease, the U.S. Centers for Disease Control and Prevention (CDC) on November 8 disclosed that the presence of vitamin E acetate was discovered in 100% of lung fluid samples from 29 patients that were submitted to the agency from 10 states.  Discuss